Factor Therapeutics Ltd (FTT):企業の財務・戦略的SWOT分析

◆英語タイトル:Factor Therapeutics Ltd (FTT) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14964
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥33,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Factor Therapeutics Ltd (FTL), formerly Tissue Therapies Ltd, is a developer of wound care therapeutics. The company develops treatments for acute and chronic wound healing applications such as chronic skin ulcers and burns. Its lead therapeutic candidate, VF-001 is a targeted growth factor which is being developed to treat venous leg ulcers. FTL offers cell culture reagents to enhance the growth of mammalian cells for cell-based therapies. The company’s VF-001 pursues the development of other product candidates which may be applicability to other wound care applications. It utilizes third parties for development and commercialization of its novel products. FTL is headquartered in Brisbane, Queensland, Australia.

Factor Therapeutics Ltd Key Recent Developments

Feb 18,2019: Factor Therapeutics –panel declines to conduct proceedings
Jan 31,2019: Factor Therapeutics: Appendix 4C – December 2018 quarter
Dec 12,2018: Factor Therapeutics: Change to composition of the board
Oct 19,2018: Factor Therapeutics: Appendix 4C – September 2018 Quarter
Jul 27,2018: Factor Therapeutics: Appendix 4c – June 2018 quarter

This comprehensive SWOT profile of Factor Therapeutics Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Factor Therapeutics Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Factor Therapeutics Ltd – Key Information
Factor Therapeutics Ltd – Overview
Factor Therapeutics Ltd – Key Employees
Factor Therapeutics Ltd – Key Employee Biographies
Factor Therapeutics Ltd – Key Operational Heads
Factor Therapeutics Ltd – Major Products and Services
Factor Therapeutics Ltd – History
Factor Therapeutics Ltd – Company Statement
Factor Therapeutics Ltd – Locations And Subsidiaries
Factor Therapeutics Ltd – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Factor Therapeutics Ltd – Business Description
Factor Therapeutics Ltd – Corporate Strategy
Factor Therapeutics Ltd – SWOT Analysis
SWOT Analysis – Overview
Factor Therapeutics Ltd – Strengths
Factor Therapeutics Ltd – Weaknesses
Factor Therapeutics Ltd – Opportunities
Factor Therapeutics Ltd – Threats
Factor Therapeutics Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Factor Therapeutics Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Factor Therapeutics Ltd, Key Information
Factor Therapeutics Ltd, Key Ratios
Factor Therapeutics Ltd, Share Data
Factor Therapeutics Ltd, Major Products and Services
Factor Therapeutics Ltd, History
Factor Therapeutics Ltd, Key Employees
Factor Therapeutics Ltd, Key Employee Biographies
Factor Therapeutics Ltd, Key Operational Heads
Factor Therapeutics Ltd, Other Locations
Factor Therapeutics Ltd, Subsidiaries
Factor Therapeutics Ltd, Key Manufacturing facilities
Factor Therapeutics Ltd, Key Competitors
Factor Therapeutics Ltd, SWOT Analysis
Factor Therapeutics Ltd, Ratios based on current share price
Factor Therapeutics Ltd, Annual Ratios
Factor Therapeutics Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Factor Therapeutics Ltd, Performance Chart
Factor Therapeutics Ltd, Ratio Charts

★海外企業調査レポート[Factor Therapeutics Ltd (FTT):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • LaSalle Hotel Properties:企業のM&A・事業提携・投資動向
    LaSalle Hotel Properties - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's LaSalle Hotel Properties Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Wells Fargo & Co (WFC):電力:M&Aディール及び事業提携情報
    Summary Wells Fargo & Company (WFC) is a financial services holding company that provides retail, commercial and wholesale banking, and corporate banking services to individuals, businesses, high-net worth individuals, and institutions, through its subsidiaries. Its major offerings include commercia …
  • Sermonix Pharmaceuticals LLC-製薬・医療分野:企業M&A・提携分析
    Summary Sermonix Pharmaceuticals LLC (Sermonix) is a biotechnology company develops female-specific oncology products. The company’s lead product include lasofoxifene, which is a selective estrogen receptor modulator. Its lasofoxifene is used in the treatment of common disorders affecting women that …
  • Brown-Forman Corporation:企業の戦略・SWOT・財務情報
    Brown-Forman Corporation - Strategy, SWOT and Corporate Finance Report Summary Brown-Forman Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • HNI Corporation:企業の戦略・SWOT・財務情報
    HNI Corporation - Strategy, SWOT and Corporate Finance Report Summary HNI Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Lakewood-Amedex Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Lakewood-Amedex Inc (Lakewood-Amedex) is a clinical-stage pharmaceutical company with focus on the development of antimicrobial and antifungal medicines to address unmet needs in the treatment of serious infectious diseases. The company develops anti-infective products such as anti-bacterial …
  • Nevro Corp (NVRO)-医療機器分野:企業M&A・提携分析
    Summary Nevro Corp (Nevro) is a medical device company that offers therapeutic equipment. The company provides pain relief therapies for low back pain and other types of chronic pain. Its services include SCS therapy and clinical trials. Nevro’s SCS therapy is a low-frequency spinal cord stimulation …
  • International Paper Co:企業のM&A・事業提携・投資動向
    International Paper Co - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's International Paper Co Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Molinos Rio de la Plata SA (MOLI3):企業の財務・戦略的SWOT分析
    Molinos Rio de la Plata SA (MOLI3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Midea Group Co Ltd:企業の戦略・SWOT・財務情報
    Midea Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Midea Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Flower Orthopedics Corp:医療機器:M&Aディール及び事業提携情報
    Summary Flower Orthopedics Corp (Flower Orthopedics) is a medical equipment provider that offers orthopedic devices. The company offers instrument kits which include K-wire kits, olive wire kits, guide wire kits, drill bit kits, lag screw kits, cannulated drill bits, trials and cannulated countersin …
  • Da Afghanistan Breshna Sherkat:企業の戦略的SWOT分析
    Da Afghanistan Breshna Sherkat - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Grupa Lotos SA (LTS):企業の財務・戦略的SWOT分析
    Grupa Lotos SA (LTS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Pakistan Water and Power Development Authority:発電所・企業SWOT分析
    Pakistan Water and Power Development Authority - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, i …
  • Linamar Corporation:企業の戦略・SWOT・財務分析
    Linamar Corporation - Strategy, SWOT and Corporate Finance Report Summary Linamar Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • HollyFrontier Corp (HFC):石油・ガス:M&Aディール及び事業提携情報
    Summary HollyFrontier Corp (HollyFrontier) is an independent energy company. It carries out crude oil refining and wholesale marketing of refined petroleum products. The company produces and markets high-value light products such as gasoline, diesel, jet fuel, specialty lubricant products, heavy pro …
  • University of Oxford:企業のM&A・事業提携・投資動向
    University of Oxford - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's University of Oxford Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Bowler Metcalf Ltd:戦略・SWOT・企業財務分析
    Bowler Metcalf Ltd - Strategy, SWOT and Corporate Finance Report Summary Bowler Metcalf Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • ASOS Plc:企業の戦略・SWOT・財務情報
    ASOS Plc - Strategy, SWOT and Corporate Finance Report Summary ASOS Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Visterra Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Visterra Inc (Visterra), formerly Parasol Therapeutics Inc is a clinical-stage biopharmaceutical company that develops antibody therapies for the treatment of infectious diseases. The company develops precision antibody-based biological medicines for infectious and non-infectious diseases. I …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆